Table 2 Pharmacological treatments and outcomes favoured by clinicians
Study | Favoured regimen | Number of Doctors |
|---|---|---|
USA 1999 [4] | Haloperidol + lorazepam +/- benztropine | 11 (55%) |
Droperidol | 4 (20%) | |
Benzodizepine (unspecified) alone | 3 (15%) | |
Droperidol + lorazepam + diphenhydramine | 1 (5%) | |
Haloperidol + benztropine | 1 (5%) | |
Use of physical restraints | ||
Common | 14 (70%) | |
Usually not used | 6 (30%) | |
Route of administration | ||
Preferred IM or IV | 14 (70%) | |
Preferred IM | 3 (15%) | |
Unknown | 3 (15%) | |
UK 1994 [7] | Chlorpromazine | 14 (50%) |
Haloperidol | 8 (29%) | |
Haloperidol + chlorpromazine | 2 (7%) | |
Droperidol | 1 (4%) | |
'Neuroleptic' | 1 (4%) | |
Haloperidol + diazepam | 1 (4%) | |
Haloeridol + lorazepam | 1 (4%) | |
Desired end point | ||
Sedated but mobile | 12 (43%) | |
Not sedated but calm | 9 (32%) | |
Asleep | 7 (25%) | |
Route of administration | ||
Preferred IM | 26 (93%) | |
Preferred IV | 2 (7%) |